The activity of the p38 pathway is entertained by autocrine stimulation of breast cancer cells with vascular endothelial growth factor (VEGF) and pharmacologic p38 inhibition could alleviate tamoxifen resistance [118]. This evidence concerns the gene VEGFA and breast carcinoma.